Shaping Animal Health for the Next Decade Zoetis Investor Day

Made public by

sourced by PitchSend

106 of 131

Creator

Zoetis logo
Zoetis

Category

Healthcare

Published

2023

Slides

Transcriptions

#1#2#3#4Agenda 9:00-9:45 9:45-10:15 10:15 10:45 10:45-11:00 11:00 - 11:30 11:30 12:15 Our Strategy & Ambitions: Kristin Peck, CEO Power of Our R&D: Robert Polzer, PhD, EVP and President of R&D Delivering Our Value Proposition: Panel Discussion • Jeannette Ferran Astorga, EVP, Corporate Affairs, Communications and Chief Sustainability Officer • Jamie Brannan, EVP and President, International Operations and Aquaculture • Wafaa Mamilli, EVP, Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health • Nick Ashton, EVP & President, Global Manufacturing and Supply Break Our Financial Roadmap: Wetteny Joseph, EVP and CFO Q&A#5Our Strategy and Ambitions Kristin Peck Chief Executive Officer zoetis#6#7#8#9#10#11#12#13#14#15#16#17#18#19#20#21#22#23#24#25#26#27#28#29#30#31#32#33#34#35#36#37#38#39#40#41#42#43#44#45#46#47#48#49#50#51#52#53#54#55#56#57#58#59#60#61#62#63#64#65#66#67#68#69#70#71#72#73#74#75#76#77#78#79#80#81#82#83#84#85#86#87#88#89#90#91#92#93#94#95#96#97#98#99#100#101#102#103#104#105#106#107#108#109#110#111#112#113#114#115#116#117#118#119#120#121

Download to PowerPoint

Download presentation as an editable powerpoint.

Related

Fiscal 3Q Investor Presentation image

Fiscal 3Q Investor Presentation

Healthcare

FY23 Full-Year Results Presentation image

FY23 Full-Year Results Presentation

Healthcare

Healthcare Network P&L Statement and Expansion Projects image

Healthcare Network P&L Statement and Expansion Projects

Healthcare

Accreditation and Quality Assurance Overview image

Accreditation and Quality Assurance Overview

Healthcare

Investment Highlights image

Investment Highlights

Healthcare

Investor Presentation image

Investor Presentation

Healthcare

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update image

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update

Healthcare

BioAtla Investor Presentation Deck image

BioAtla Investor Presentation Deck

Healthcare